A Brexecutive Briefing on the pharma sector… The Confederation of British Industry (CBI) says that although non-EU pharma trade is growing faster, the EU still accounts for around 56% of UK pharmaceutical exports, totalling £53bn (US$69bn). Post-Brexit trade in pharma products is therefore a key concern within the industry, as is regulatory control. The London-based Read more about PHARMA FACTS[…]